“…The derivatives included in the first two classes were designed based on the specific chemical properties of amino acids resulting from reactions at the carboxyl and amino functional groups. Blocking these essential functional groups in the amino acid’s structure could bring significant changes in terms of its biochemical metabolism; consequently, derivatives with potential pharmaceutical effects are sought [ 24 , 25 , 26 , 27 ]. The following classes of compounds comprise structures containing pharmacophores responsible for the anti-cancer effect: thiazole derivatives, 1,3-oxazole derivatives [ 28 , 29 , 30 ], alkylating agents [ 28 , 31 , 32 , 33 , 34 , 35 ], inhibitors of histone deacetylase [ 36 , 37 , 38 , 39 ], ribonucleotide reductase [ 40 , 41 , 42 ], glutamate synthetase inhibitors, and mitochondrial transporters of the SLC25A family [ 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 ].…”